Synopsis
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
51
PharmaCompass offers a list of Bifonazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bifonazole manufacturer or Bifonazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bifonazole manufacturer or Bifonazole supplier.
PharmaCompass also assists you with knowing the Bifonazole API Price utilized in the formulation of products. Bifonazole API Price is not always fixed or binding as the Bifonazole Price is obtained through a variety of data sources. The Bifonazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bifonazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bifonazole, including repackagers and relabelers. The FDA regulates Bifonazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bifonazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bifonazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bifonazole supplier is an individual or a company that provides Bifonazole active pharmaceutical ingredient (API) or Bifonazole finished formulations upon request. The Bifonazole suppliers may include Bifonazole API manufacturers, exporters, distributors and traders.
click here to find a list of Bifonazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bifonazole DMF (Drug Master File) is a document detailing the whole manufacturing process of Bifonazole active pharmaceutical ingredient (API) in detail. Different forms of Bifonazole DMFs exist exist since differing nations have different regulations, such as Bifonazole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bifonazole DMF submitted to regulatory agencies in the US is known as a USDMF. Bifonazole USDMF includes data on Bifonazole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bifonazole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bifonazole suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bifonazole Drug Master File in Japan (Bifonazole JDMF) empowers Bifonazole API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bifonazole JDMF during the approval evaluation for pharmaceutical products. At the time of Bifonazole JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bifonazole suppliers with JDMF on PharmaCompass.
A Bifonazole CEP of the European Pharmacopoeia monograph is often referred to as a Bifonazole Certificate of Suitability (COS). The purpose of a Bifonazole CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bifonazole EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bifonazole to their clients by showing that a Bifonazole CEP has been issued for it. The manufacturer submits a Bifonazole CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bifonazole CEP holder for the record. Additionally, the data presented in the Bifonazole CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bifonazole DMF.
A Bifonazole CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bifonazole CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bifonazole suppliers with CEP (COS) on PharmaCompass.
A Bifonazole written confirmation (Bifonazole WC) is an official document issued by a regulatory agency to a Bifonazole manufacturer, verifying that the manufacturing facility of a Bifonazole active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bifonazole APIs or Bifonazole finished pharmaceutical products to another nation, regulatory agencies frequently require a Bifonazole WC (written confirmation) as part of the regulatory process.
click here to find a list of Bifonazole suppliers with Written Confirmation (WC) on PharmaCompass.
Bifonazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bifonazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bifonazole GMP manufacturer or Bifonazole GMP API supplier for your needs.
A Bifonazole CoA (Certificate of Analysis) is a formal document that attests to Bifonazole's compliance with Bifonazole specifications and serves as a tool for batch-level quality control.
Bifonazole CoA mostly includes findings from lab analyses of a specific batch. For each Bifonazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bifonazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Bifonazole EP), Bifonazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bifonazole USP).
